Mr. Ivan Miliovski reports

VODIS PHARMACEUTICALS INC. ANNOUNCES $1,300,000 NON-BROKERED PRIVATE PLACEMENT

Vodis Pharmaceuticals Inc. has arranged a private placement of 20,006,000 units of the company to various investors, including insiders, at a price of 6.5 cents per unit for total proceeds of $1,300,390. Each unit will consist of one common share and one non-transferable share purchase warrant. Each warrant will entitle the holder to purchase one additional common share at a price of eight cents at any time for two years from the closing date. The shares issued in connection of the private placement will have a hold period expiring four months and one day after the closing date.

The company will not pay any finders' fees in cash or securities in connection with the private placement.

Ivan Miliovski, chief executive officer and director, commented: "We are extremely pleased that the investor community continues to support the direction the company has taken as we continue to invest in our Washington State assets to meet the expansion requirements of our tenants in a booming Washington State marijuana market."

The proceeds of the private placement will be used for expansion into Washington in the United States and general working capital purposes.

About Vodis

Vodis is one of North America's foremost brand names in the medical and recreational marijuana business with operations in both the United States and Canada. The company, with facilities in British Columbia and Washington, is also actively looking into expansion opportunities in other countries and U.S. states.

We seek Safe Harbor.